Investors past and present pay close attention.On December 1, 2016 a press release was written
DECN Increases Manufacturing Capacity, Opens International Markets for Popular GenUltimate!
COMPANY INCREASES MONTHLY FACTORY OUTPUT TO 620,000 UNITS, SCHEDULES LARGE SHIPMENTS ON $17.2 MILLION IN INTERNATIONAL ORDERS RECEIVED
You may want to investigate Uni care and Macre Diagnostics S.R.L
By the company penned by Keith M Berman stating to the investment community that he has received 17.2 million in orders and has increased manufacturing capacity to fulfill this order for year 2017, you should see this on the year end report.
If you made an investment decision in Decision Diagnostics Corp. based on 17.2 million in sales orders with 80 million shares out at that time to come up with a Earnings Per Share multiple, you have recourse.
The last 20 years of press releases, I have not found one to have come true.
Investors willing to take a loss and walk away or become jaded and decide never to invest in this market segment again is the wrong attitude.
Deception occurs until corrected. Wrongs can be righted "and it is always worth it"
Sometimes shareholders need to take the moral high ground and insist on transparency with full audited disclosure.
Keith M Berman is now printing 20 million shares a year and as the outstanding continues and he continues this 20 percent print rate could sink a ship.
These listed consultants from the last 20 years have an enormous amount of SEC fraud convictions. Why a company is consulting with SEC stock frauds is beyond comprehension. Shouldn't consultants be in the In Vitro Diagnostic Engineering business? Where are those names? Why are the more recent share issuances hidden as "consultants"
When Keith M Berman states his role is to always raise other peoples money, Why? over 55 million dollars raised of discounted stock shares. Some recently as low as 6 tenths of one penny. Why?
Where are the assets to back up these questionable debt issuances for free trading shares?
Uni-Care Corp
Seoul, South Korea
Macre Diagnosis S.R.L.
Santa Cruz, Bolivia
Keith Berman, PEO of Decision Diagnostics commented, "It is gratifying and highly appropriate that immediately following the Thanksgiving holiday we are in a position to update our shareholders and the entire investment community regarding the continuation of our efforts to execute our marketing plan, and to communicate the initial fruits of those tactical endeavors. We are all thankful for the loyalty of our investors and the support of our customers."
The Company has contracted Uni-Care Corp to exclusively distribute the Gen family of test strips to the Republic of South Korea, China and the Philippines. Uni-Care has activated the arrangement with the submission of an initial stocking purchase order for approximately 40,000 pieces of GenUltimate! test strips to be shipped immediately following the product's registration with South Korea's KFDA regulatory agency, expected in early December. Additional stocking orders are expected from sub-distributors in China and the Philippines. The Uni-Care Exclusive Distribution Agreement requires the annual purchase of a minimum of 250,000 GenUltimate! units in the next 12 months.
" it doesn't matter if its other peoples money"
